Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline" report to their offering.

The report Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline is a comprehensive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications. This pipeline is also benchmarked against its size across each segment compared to 2015 and 2016, and an assessment of the level of first-in-class innovation is provided. In addition, a detailed contextual analysis of the key drivers of this pipeline is provided, in addition to an assessment of companies present in the pipeline and historical deal value and volume.

Scope

  • What is the current size and composition of the pharmaceutical industry pipeline and how has it changed in the last two years? What can we learn from this?
  • The largest therapy area, by a substantial margin, is oncology, and, with growth in the pipeline sizes for all major oncology indications since Q1 2015, this trend appears set to continue. Why is this the case?
  • What is the overall advantage for companies including first-in-class product developments in their pipeline portfolio, rather than opting for better-characterized established molecular targets?
  • What factors have been driving the increasing number of first-in-class product approvals over recent decades?
  • Historically, what has the risk of clinical trial attrition been across each therapy area and molecule type in the pharmaceutical industry?
  • How long have their associated clinical trials been and how many patients, on average, were recruited?

Key Topics Covered:

1 Contents

2 Introduction

3 Assessment of the Pharmaceutical Industry Pipeline

4 Assessment of Innovation in the Pharmaceutical Industry Pipeline

5 Assessment of the Pharmaceutical Industry Clinical Trial Landscape

6 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/v35snq/innovation_and

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials